Projects funded by the NCN
Comparison of cardioprotective effects of metformin and resveratrol on cardiomyocytes treated with epirubicin and trastuzumab.
2012/05/N/NZ7/01936
Keywords:
cardiomyocytes cardiac stem cells cardioprotection breast cancer epirubicin trastuzumab
Descriptors:
- NZ7_12: Prevention of human diseases
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_15: Toxicology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Fundacja Rozwoju Kardiochirurgii im. prof. Z Religi
woj. śląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 3 - announced on 2012-03-15
Amount awarded: 149 730 PLN
Project start date (Y-m-d): 2013-04-11
Project end date (Y-m-d): 2014-12-22
Project duration:: 20 months (the same as in the proposal)
Project status: Project settled
Information in the final report
- Publication in academic press/journals (1)
- Articles in post-conference publications (2)
- Kardiotoksyczność jako niepożądane działanie uboczne w terapii raka piersiAuthors:Michalina GramatykaAcademic press:Postępy Higieny i Medycyny Doświadczalnej (rok: 2014, tom: 68, strony: 483-498), Wydawca: Index Copernicus InternationalStatus:PublishedDOI:10.5604/17322693.1101581 - link to the publication
- Toxicity of epirubicin and trastuzumab to human cardiomyocytes and breast cancer cells in vitroAuthors:Michalina GramatykaConference:XVIIth Gliwice Scientific Meetings (rok: 2013, ), Wydawca: --Data:konferencja 15-16 listopadStatus:Published
- Metformin and resveratrol do not show cytoprotective activity in cardiomyocytes exposed to ionizng radiation and/or epirubicin.Authors:Michalina Gramatyka, Piotr WidłakConference:XVIII Gliwickie Spotkania Naukowe (rok: 2014, ), Wydawca: --Data:konferencja 21-22.11Status:Published